Periodontal disease: associations with diabetes, glycemic control and complications.
暂无分享,去创建一个
[1] P. Baeuerle,et al. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.
[2] A. Baird,et al. Does Periodontal Treatment Improve Glycemic Control in Diabetic Patients? A Meta-analysis of Intervention Studies , 2005, Journal of dental research.
[3] C. Greenbaum,et al. Short-term responses to periodontal therapy in insulin-dependent diabetic patients. , 1996, Journal of periodontology.
[4] J. Beck,et al. Periodontal Infection as a Possible Risk Factor for Preterm Low Birth Weight. , 1996, Journal of periodontology.
[5] Y. Khader,et al. Periodontal status of diabetics compared with nondiabetics: a meta-analysis. , 2006, Journal of diabetes and its complications.
[6] A. Bascones,et al. Clinical and metabolic changes after conventional treatment of type 2 diabetic patients with chronic periodontitis. , 2006, Journal of periodontology.
[7] K. Roberts-Thomson,et al. Anangu oral health: the status of the Indigenous population of the Anangu Pitjantjatjara lands. , 2004, The Australian journal of rural health.
[8] A. Schmidt,et al. The biology of the receptor for advanced glycation end products and its ligands. , 2000, Biochimica et biophysica acta.
[9] A. Kingman,et al. Gingival recession, gingival bleeding, and dental calculus in adults 30 years of age and older in the United States, 1988-1994. , 1999, Journal of periodontology.
[10] G. Maupomé,et al. Risk factors and prevalence of periodontitis in community-dwelling elders in Mexico. , 2006, Journal of clinical periodontology.
[11] M. Taba,et al. Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. , 2003, Journal of periodontology.
[12] T. Kislinger,et al. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. , 2001, The American journal of pathology.
[13] U. Skalerič,et al. Periodontal disease and diabetes metabolic control: a full-mouth disinfection approach. , 2006, Journal of the International Academy of Periodontology.
[14] J. Lindhe,et al. The effect of periodontal therapy in diabetics. Results after 5 years. , 1996, Journal of clinical periodontology.
[15] Brian Burt,et al. Position paper: epidemiology of periodontal diseases. , 2005, Journal of periodontology.
[16] P. Papapanou,et al. Periodontal diseases: epidemiology. , 1996, Annals of periodontology.
[17] P. Baeuerle. The inducible transcription activator NF-κB: regulation by distinct protein subunits , 1991 .
[18] T. Collins. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[19] P. Guillausseau,et al. Rapid Publication , 1971, Nature.
[20] Nicollerat Ja. Implications of the United Kingdom Prospective Diabetes Study , 1998, Diabetes Care.
[21] H. Murtomaa,et al. Periodontal treatment needs in a follow-up study among adults with diabetes in Finland , 2003, Acta odontologica Scandinavica.
[22] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[23] J M Albandar,et al. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994. , 1999, Journal of periodontology.
[24] K. Wikblad,et al. Type 2 diabetes and oral health: a comparison between diabetic and non-diabetic subjects. , 2000, Diabetes research and clinical practice.
[25] J. Beck,et al. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression. , 1998, Annals of periodontology.
[26] E. Ogata,et al. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. , 1994, Endocrinology.
[27] S. Vannucci,et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. , 2005, Glycobiology.
[28] W. Knowler,et al. Severe Periodontitis and Risk for Poor Glycemic Control in Patients with Non-Insulin-Dependent Diabetes Mellitus. , 1996, Journal of periodontology.
[29] D. Graves,et al. Diabetes-enhanced Inflammation and Apoptosis—Impact on Periodontal Pathology , 2006, Journal of dental research.
[30] L. Forman,et al. Oral health in the elderly with non-insulin-dependent diabetes mellitus. , 2002, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.
[31] A. Hanlon,et al. Periodontal treatment by Arestin and its effects on glycemic control in type 1 diabetes patients. , 2004, Journal of the International Academy of Periodontology.
[32] Hsein-Kun Lu,et al. Cross-sectional analysis of different variables of patients with non-insulin dependent diabetes and their periodontal status. , 2004, The International journal of periodontics & restorative dentistry.
[33] E. Baldoni,et al. Diabetes and periodontal disease: a case-control study. , 2005, Journal of periodontology.
[34] M. Brownlee. Lilly Lecture 1993. Glycation and diabetic complications. , 1994, Diabetes.
[35] C. Deerochanawong,et al. The Effect of Periodontal Therapy on Uncontrolled Type 2 Diabetes Mellitus in Older Subjects , 2005 .
[36] F. Nishimura,et al. The Periodontal Host Response with Diabetes Pathogenesis of Periodontal Disease in Diabetic Subjects , 2022 .
[37] D. Barrio,et al. Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK) , 2003, Molecular and Cellular Biochemistry.
[38] O. Fatusi,et al. Oral health status in a population of Nigerian diabetics. , 2005, The journal of contemporary dental practice.
[39] G. Schmalz,et al. Healing response to non-surgical periodontal therapy in patients with diabetes mellitus: clinical, microbiological, and immunologic results. , 1998, Journal of clinical periodontology.
[40] W. Knowler,et al. Effect of Periodontitis on Overt Nephropathy and End-Stage Renal Disease in Type 2 Diabetes , 2007, Diabetes Care.
[41] David Haber,et al. Guide to clinical preventive services: a challenge to physician resourcefulness , 1993 .
[42] Y. Zou,et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. , 1993, The American journal of pathology.
[43] Jeng-Jong Huang,et al. Oral and dental manifestations in diabetic and nondiabetic uremic patients receiving hemodialysis. , 2005, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[44] D. Bourgeois,et al. Type 2 diabetes and periodontal indicators : epidemiology in France 2002-2003 , 2006 .
[45] H. Michie,et al. Metabolism of Sepsis and Multiple Organ Failure , 1996, World Journal of Surgery.
[46] R. Bouillon,et al. Diabetic bone disease , 2007, Calcified Tissue International.
[47] F. A. Blanco,et al. Problemas bucodentales en pacientes con diabetes mellitus (II): indice gingival y enfermedad periodontal , 2003 .
[48] A. Schmidt,et al. Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes. , 1998, Annals of periodontology.
[49] Plamen Nikolov,et al. Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.
[50] G. Taylor,et al. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. , 2002, Community dentistry and oral epidemiology.
[51] G. Taylor. Periodontal treatment and its effects on glycemic control: a review of the evidence. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[52] H. Vlassara. Recent progress on the biologic and clinical significance of advanced glycosylation end products. , 1994, The Journal of laboratory and clinical medicine.
[53] K. Wager,et al. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. , 2001, Journal of clinical periodontology.
[54] Simon Smyth,et al. Diabetes and obesity: the twin epidemics , 2006, Nature Medicine.
[55] D. Graves,et al. A role for advanced glycation end products in diminished bone healing in type 1 diabetes. , 2003, Diabetes.
[56] S. Takashiba,et al. Assessment of interleukin-6 in the pathogenesis of periodontal disease. , 1994, Journal of periodontology.
[57] D. Graves,et al. Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. , 2003, Endocrinology.
[58] P. Buekens,et al. Periodontal disease and gestational diabetes mellitus. , 2005, American journal of obstetrics and gynecology.
[59] D. Rogers,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus , 1994 .
[60] J. J. Arrieta-Blanco,et al. Dental problems in patients with diabetes mellitus (II): gingival index and periodontal disease. , 2003, Medicina oral : organo oficial de la Sociedad Espanola de Medicina Oral y de la Academia Iberoamericana de Patologia y Medicina Bucal.
[61] G. Taylor,et al. Periodontitis and gestational diabetes mellitus: exploring the link in NHANES III. , 2006, Journal of public health dentistry.
[62] M. Matsumoto,et al. Rage: A Novel Cellular Receptor for Advanced Glycation End Products , 1996, Diabetes.
[63] James A Rothendler,et al. Does periodontal care improve glycemic control? The Department of Veterans Affairs Dental Diabetes Study. , 2007, Journal of clinical periodontology.
[64] G. Taylor. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. , 2001, Annals of periodontology.
[65] T. Fukuda,et al. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. , 2001, Journal of periodontology.
[66] C Lindh,et al. Type 2 diabetes and risk for periodontal disease: a role for dental health awareness. , 2006, Journal of clinical periodontology.
[67] L. Niskanen,et al. Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. , 1998, Journal of periodontology.
[68] Y. Zou,et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. , 1994, The Journal of biological chemistry.
[69] Jennifer L. Talbert,et al. The effect of periodontal therapy on TNF-alpha, IL-6 and metabolic control in type 2 diabetics. , 2006, Journal of dental hygiene : JDH.
[70] A. Schmidt,et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. , 1995, The Journal of clinical investigation.
[71] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[72] M. Kawanami,et al. Effect of lifestyle on periodontal disease status in diabetic patients. , 2004, Journal of the International Academy of Periodontology.
[73] T. Kislinger,et al. Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. , 2000, The Journal of clinical investigation.
[74] Robert L Hanson,et al. Periodontal disease and mortality in type 2 diabetes. , 2005, Diabetes care.
[75] J. Hood. American Academy of Periodontology , 1921 .
[76] M. Brownlee. Glycation and Diabetic Complications , 1994, Diabetes.
[77] J. Wolf. Dental and periodontal conditions in diabetes mellitus. A clinical and radiographic study. , 1977, Proceedings of the Finnish Dental Society. Suomen Hammaslaakariseuran toimituksia.
[78] V. Çanakçi,et al. The Influence of Smoking and Non-Insulin-Dependent Diabetes Mellitus on Periodontal Disease , 2002, The Journal of international medical research.
[79] M. Thornhill,et al. Endothelial cell leukocyte adhesion molecule-1 (ELAM-1) and intercellular adhesion molecule-1 (ICAM-1) expression in gingival tissue during health and experimentally-induced gingivitis. , 1992, Journal of periodontal research.
[80] M. Reding,et al. The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 cases. , 1992, Journal of periodontology.
[81] R. Schmidt,et al. Effect of Aminoguanidine on the Frequency of Neuroaxonal Dystrophy in the Superior Mesenteric Sympathetic Autonomic Ganglia of Rats With Streptozocin-Induced Diabetes , 1996, Diabetes.
[82] N. Istfan,et al. Differential effects of interleukin-1 receptor antagonist in cytokine- and endotoxin-treated rats. , 1995, The American journal of physiology.
[83] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[84] A. Schmidt,et al. A murine model of accelerated periodontal disease in diabetes. , 2010, Journal of periodontal research.
[85] K. Feingold,et al. Evidence for two classes of cytokines that stimulate hepatic lipogenesis: relationships among tumor necrosis factor, interleukin-1 and interferon-alpha. , 1990, Endocrinology.
[86] P. Baeuerle. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. , 1991, Biochimica et biophysica acta.
[87] K. Feingold,et al. Role of Cytokines in Inducing Hyperlipidemia , 1992, Diabetes.
[88] J. Ainamo,et al. A longitudinal study on insulin-dependent diabetes mellitus and periodontal disease. , 1993, Journal of clinical periodontology.
[89] J. Ainamo,et al. A site-by-site follow-up study on the effect of controlled versus poorly controlled insulin-dependent diabetes mellitus. , 1994, Journal of clinical periodontology.
[90] E. Sato,et al. [Reactive oxygen]. , 2002, Nihon eiseigaku zasshi. Japanese journal of hygiene.
[91] R. Genco,et al. Periodontal disease and diabetes mellitus: a two-way relationship. , 1998, Annals of periodontology.
[92] T. Watts. Diabetes mellitus promotes periodontal destruction in children , 2007, BDJ.
[93] A. Dedić,et al. [Diabetes mellitus and periodontal diseases]. , 1998, Medicinski arhiv.
[94] E. Koumantakis,et al. Gingival condition of women with gestational diabetes on a Greek island. , 2006, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.
[95] M. Serio,et al. Multiple cytokines stimulate hepatic lipid synthesis in vivo. , 1989, Endocrinology.
[96] K. Kuwabara,et al. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[97] G. Gill,et al. Oral health in rural South African type 2 diabetic patients , 2006, Tropical doctor.
[98] S. Etcheverry,et al. Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development , 2001, Acta Diabetologica.
[99] J. Pickup,et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X , 1997, Diabetologia.
[100] S. Genuth. Lowering the criterion for impaired fasting glucose is in order. , 2003, Diabetes care.
[101] A. Schmidt,et al. Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. , 1996, Journal of periodontal research.
[102] R. Williams,et al. Periodontal disease and diabetes in young adults. , 1960, Journal of the American Medical Association.
[103] S. Huumonen,et al. Alveolar bone loss in type 1 diabetic subjects. , 2000, Journal of clinical periodontology.
[104] T. V. Van Dyke,et al. Association between interleukin-1 genotype and periodontal disease in a diabetic population. , 2003, Journal of periodontology.
[105] G. Viberti,et al. Single-blind studies of the effects of improved periodontal health on metabolic control in type 1 diabetes mellitus. , 1995, Journal of clinical periodontology.
[106] G. Taylor,et al. Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease. , 2006, Periodontology 2000.
[107] R. Genco,et al. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. , 1997, Journal of periodontology.
[108] M. Erdoğan,et al. The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus. , 2005, Journal of clinical periodontology.
[109] A. Hugoson,et al. Medical status and complications in relation to periodontal disease experience in insulin-dependent diabetics. , 1996, Journal of clinical periodontology.
[110] R. Genco,et al. Response to Periodontal Therapy in Diabetics and Smokers. , 1996, Journal of periodontology.